FindTrial
Sign In

Estimation and comparison of salivary inflammatory biomarkers and alpha amylase in type 1 diabetic and non diabetic children

Estimation and comparison of salivary cytokines and alpha amylase in whole saliva of children with type 1 Diabetes Mellitus and Non Diabetic children - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/064932
Enrollment
40
Registered
2024-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E109- Type 1 diabetes mellitus without complications

Interventions

Control Intervention1: NIL: NIL

Sponsors

DR PRIYANKA N
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1Children of 7-15 years of age. 2Children with insulin dependent type 1 diabetes mellitus disorder. 3Parents giving consent for the study

Exclusion criteria

Exclusion criteria: 1 Children with presence of any physical or mental disorder. 2 Children requiring special health care needs. 3 Children with genetic diseases or syndromes. 4 Children on any other systemic medications.

Design outcomes

Primary

MeasureTime frame
To estimate and compare the levels of salivary cytokines using ELISA .To estimate and compare the levels of alpha amylase using UV spectrometer in diabetic and non-diabetic childrenTimepoint: baseline—

Secondary

MeasureTime frame
estimating the values of salivary cytokinesTimepoint: baseline—

Countries

India

Contacts

Public ContactDr Priyanka N

RajaRajeswari Dental college and hospital

shakuntalabethur@gmail.com9945380455

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026